Flynn James E 13D and 13G filings for Mirum Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-05-03 4:58 pm Sale |
2023-05-03 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
Flynn James E | 0 0.000% |
-2,032,335 (Position Closed) |
Filing |
| 2023-02-10 09:34 am Unchanged |
2022-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
Flynn James E | 2,032,335 5.510% |
0 (Unchanged) |
Filing |
| 2022-09-12 5:23 pm Sale |
2022-09-08 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
Flynn James E | 2,032,335 5.530% |
-1,250,577 (-38.09%) |
Filing |
| 2022-02-11 4:11 pm Sale |
2021-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
Flynn James E | 3,282,912 10.720% |
-166,000 (-4.81%) |
Filing |